Cho Pharma Inc. (6586)
TWSE
115.00
+0.50 (+0.44%)
Closed
Oct 8, 2026
Day's Range
113.50116.00
52 wk Range
22.75148.50
Financial Statements - 6586 - Cho Pharma Inc.
Revenue
1.43M▼ 60.0%
Net Income
-290.00M▼ 36.6%Net Margin -20266.0%
EBITDA
-262.90M▼ 41.6%
Free Cash Flow
-291.27M▼ 30.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 1.43M | 3.58M | 0 | 60K | 3.57M | 138K |
| Cost of Goods | 365K | 1.87M | 0 | 1K | 211K | 71K |
| Gross Profit | 1.06M | 1.71M | 0 | 59K | 3.35M | 67K |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -325.84M | -249.29M | -268.99M | -350.90M | -210.49M | -309.55M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | -290M | -212.22M | -306.08M | -338.39M | -205.92M | -296.83M |
| Income Tax | - | - | - | - | - | - |
| Net Income | -290M | -212.22M | -306.08M | -338.39M | -205.92M | -296.83M |
| EPS Basic | -1.36 | -0.99 | -1.6 | -1.84 | -1.12 | -1.62 |
| EPS Diluted | -1.36 | -0.99 | -1.6 | -1.84 | -1.12 | -1.62 |
| Basic Shares Outstanding | 214.01M | 214.01M | 191.32M | 183.96M | 183.88M | 183.67M |
| Diluted Shares Outstanding | 214.01M | 214.01M | 191.32M | 183.96M | 183.88M | 183.67M |
| Ebit | -289.60M | -211.54M | -306.01M | -338.09M | -205.34M | -296.06M |
| Ebitda | -262.90M | -185.64M | -277.73M | -298.24M | -166.26M | -254.82M |
| Net Income Continuous Operations | -290M | -212.22M | -306.08M | -338.39M | -205.92M | -296.83M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
